Administration of Aggregated Beta-Amyloid Peptide (25-35) Induces Changes in Long-Term Potentiation in Hippocampus in vivo

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 51, Issue 6, 2001, Pages 693-

  Trubetskaya, V V ^a   Stepanichev, M Yu ^a   Onufriev, M V ^a   Lazareva, N A ^a   Markevich, V A ^a   Gulyaeva, N V ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037957874     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Carette B., Poulain P., Delacourt A. Electrophysiological effects of 25-35 amyloid-β-protein on guinea-pig lateral septal neurons // Neurosci. Lett. 1993. V. 151. P. 111-114.
2. Chapman P.F., White G.L., Jones M.W. et al. Impared synaptic plasticity and learning in aged amyloid precursor protein transgenic mice // Nat. Neurosci. 1999. V. 2. P. 271-276.
3. Chen Q.-S., Kagan B., Hirakura Y., Xie C.-W. Impairment of hippocampal long-term potentiation by Alzheimer amyloid β-peptides // J. Neurosci. Res. 2000. V. 60. P. 65-72.
4. Cullen W.K., Suh Y.-H., Anwyl R., Rowan M.J. Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments // NeuroReport. 1997. V. 8. P. 3213-3217.
5. Delobette S., Privat A., Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat//Europ. J. Pharmacol. 1997. V. 319. P. 1-4.
6. Gulyaeva N.V., Viktorov I.V., Stepanichev M.Yu. et al. Intracerebroventricular administration of beta-amyloid peptide (25-35) induces oxidative stress and neurodegeneration in rat brain // Progress in Alzheimer's and Parkinson's Disease / Eds Fisher A. et al. N. Y.: Plenum Press, 1998. P. 89-98.
7. Holsher C. β-amyloid induced reduction in synaptic transmission is reversed by inhibitors of nitric oxide synthase // NeuroReport. 1998. V. 9. P. 1245-1248.
8. Kowall N., McKee A., Yankner B., Beal M. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment // Neurobiol. Aging. 1992. V. 13. P. 537-542.
9. Markevich V., Scorsa A.M., Dawe G.S., Stephenson J.D. Cholinergic facilitation and inhibition of long-term potentiation of CA1 pyramidal cells in the hippocampus of uretane-anaesthetized rats // Brain Res. 1997. V. 754. P. 95-102.
10. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity // Trends Neurosci. 1998. V. 21. P. 53-57.
11. Maurice T., Lockhart B., Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction // Brain Res. 1996. V. 706. P. 181-189.
12. McDonald M.P., Overmier J.B. Present imperfect: A critical review of animal models of the mnemonic impairments in Alzheimer's disease // Neurosci. Biobehav. Rev. 1998. V. 22. P. 99-120.
13. Nalbantoglu J., Tirado-Santiago G., Lahsaini A. et al. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein // Nature. 1997. V. 387. P. 500-505.
14. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. New York, London: Acad. Press, 1986. 324 p.
15. Stepanichev M.Yu., Onufriev M.V., Mitrokhina O.S. et al. Neurochemical, behavioral, and neuromorphological effects of central administration of beta-amyloid peptide (25-35) in rat // HeôpoxHMHH. 2000. T. 17. C. 291-306.
16. Sweeney W., Luedtke J., McDonald M.P., Overmier J.B. Intrahippocampal β-amyloid impairs win-shift radial maze perfomance in rats // Neurobiol. Learn. Memory. 1997. V. 68. P. 97-101.
17. Terry R.D., Masliah E., Hansen L.A. Structural basis of cognitive alterations in Alzheimer's disease // Alzheimer Disease / Eds Terry R.D., Katzman R., Bick N. N.Y.: Raven Press, 1994. P. 179-196.
18. Wu J., Anwyl R., Rowan M.J. β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus // NeuroReport. 1995. V. 6. P. 2409-2413.
19. Wu J., Anwyl R., Rowan M.J. Beta-amyloid (1-40) increases long-term potentiation in rat hippocampus in vitro // Europ. J. Pharmacol. 1995. V. 284. P. 1-3.
20. Yermolaeva O., Brot N., Weissbach H. et al. Reactive oxygen species and nitric oxide mediate plasticity of neuronal calcium signaling // Proc. Natl. Acad. Sci. USA. 2000. V. 97. P. 448-453.
21. Yan S., Chen X., Fu J. et al. RAGE and amyloid β peptide neurotoxicity in Alzheimer's disease // Nature. 1996. V. 382. P. 685-691.
22. Yankner B., Duffy L., Kirshner D. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides // Science. 1990. V. 250. P. 279-282.